[ACRX] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
14-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 68.95%
YoY- 79.90%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 117 253 0 252 507 570 442 -58.74%
PBT -1,416 -4,425 64 -7,485 -6,739 70,666 -8,674 -70.09%
Tax 2 3 -5,273 -1 11 3 -321 -
NP -1,357 -4,371 5,337 -7,484 -6,750 70,663 -8,353 -70.19%
Tax Rate - - 8,239.06% - - -0.00% - -
Total Cost 1,474 4,624 -5,337 7,736 7,257 -70,093 8,795 -69.56%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -1,159.83 -1,727.67 0.00 -2,969.84 -1,331.36 12,397.02 -1,889.82 -27.75%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.08 -0.40 0.49 -1.01 -0.91 9.60 -1.15 -83.05%
EPS Diluted -0.08 -0.40 0.49 -1.01 -0.91 9.60 -1.15 -83.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.